Related Experiment Videos
[Barrett's esophageal adenocarcinoma]
1Dept. of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 30, 2004
Summary
Barrett
Area of Science:
- Gastroenterology and Oncology
Context:
- Barrett's esophagus, associated with gastro-esophageal reflux disease (GERD), is a precursor to esophageal adenocarcinoma.
- While rare in Eastern countries, esophageal adenocarcinoma incidence is rising globally, mirroring Western trends.
Purpose:
- To review current understanding and management of Barrett's esophageal adenocarcinoma.
- To highlight advancements in surveillance, endoscopic treatment, and chemoprevention for Barrett's esophagus.
Summary:
- Barrett's esophageal adenocarcinoma diagnosis relies on endoscopy and pathological biopsy.
- Treatment has evolved from surgical resection to include definitive or neoadjuvant chemoradiotherapy.
Impact:
- Informs clinical practice regarding the diagnosis and treatment of a growing cancer.
- Emphasizes the importance of surveillance and emerging therapeutic strategies for Barrett's esophagus.